epigallocatechin gallate (CID 65064) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(131)
 
 
Inactive(278)
 
 
Inconclusive(24)
 
 
Unspecified(223)
 
 
Top Targets:
beta secretas..(22)
 
 
 
 
alkPPc(12)
 
 
 
NR LBD PPAR(11)
 
 
 
7TM GPCR Srx(10)
 
 
Bcl-2 like(8)
 
 
 
BioAssay Types:
Literature(348)
 
 
 
 
 
Screening(153)
 
 
 
 
Confirmatory(123)
 
 
 
 
Summary(1)
 
 
BioActivity Types:
IC50(92)
 
 
 
 
 
Potency(82)
 
 
 
 
EC50(14)
 
 
 
 
 
Ki(5)
 
 
Kd(1)
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 641    Data Row: 656   Total Pages: 14   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103226312]
Ki 0.008Inhibition of Plasmodium falciparum ENR in presence of triclosan [AID277587, Type: Literature]Enoyl-acyl-carrier protein reductase precursor [gi:74844868]
View
2
[SID103226312]
Ki 0.028Competitive inhibition of Spiroplasma sp. MQ1 SssI methyltransferase using pUC18 as substrate measured for 10 mins by Dixon plot analysis [AID675175, Type: Literature]
View
3
[SID103226312]
EC50 0.03987Neuroprotection against beta-amyloid peptide 1-42-induced toxicity in human SH-SY5Y cells assessed as lactate dehydrogenase release [AID392677, Type: Literature]
View
4
[SID103226312]
Ki 0.079Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate [AID277586, Type: Literature]Enoyl-acyl-carrier protein reductase precursor [gi:74844868]
View
5
[SID103226312]
IC50 0.086Inhibition of chymotrypsin like activity of proteasome [AID461136, Type: Literature]
View
6
[SID103226312]
IC50 0.18Inhibition of beta amyloid (1 to 40) fibril formation [AID456194, Type: Literature]
View
7
[SID103226312]
Ki 0.186Inhibition of Plasmodium falciparum ENR using NADH substrate [AID277585, Type: Literature]Enoyl-acyl-carrier protein reductase precursor [gi:74844868]
View
8
[SID103226312]
IC50 0.2Inhibition of FabI [AID265759, Type: Literature]Enoyl-acyl-carrier protein reductase precursor [gi:74844868]
View
9
[SID103226312]
IC50 0.2Inhibition of chymotrypsin like activity of 20S proteasome [AID300029, Type: Literature]
View
10
[SID103226312]
IC50 0.25Inhibition of Plasmodium falciparum ENR [AID277583, Type: Literature]Enoyl-acyl-carrier protein reductase precursor [gi:74844868]
View
11
[SID103226312]
IC50 0.25Inhibition of yeast G6PD [AID319369, Type: Literature]Glucose-6-phosphate 1-dehydrogenase [gi:120734]
View
12
[SID103226312]
IC50 0.3Inhibition of FabG [AID265760, Type: Literature]3-oxoacyl-acyl-carrier protein reductase precursor [gi:75020671]
View
13
[SID103226312]
EC50 0.391Antiviral activity against Influenza (A/PR8/34(H1N1)) [AID343516, Type: Literature]
View
14
[SID103226312]
IC50 0.4Inhibition of FabZ [AID265758, Type: Literature]Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) [gi:74844869]
View
15
[SID26719730]
Potency 0.4467qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory]DNA polymerase beta [Homo sapiens] [gi:4505931]
View
16
[SID26719730]
Potency 0.4467qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory]DNA polymerase beta [Homo sapiens] [gi:4505931]
View
17
[SID103226312]
IC50 0.69Compound was evaluated for its inhibitory activity against recombinant rat SE(squalene epoxidase) [AID204664, Type: Literature]
View
18
[SID103226312]
IC50 0.69Inhibition of rat squalene epoxidase [AID357310, Type: Literature]Squalene monooxygenase [gi:1706689]
View
19
[SID103226312]
IC50 0.72Inhibition of 6PGD [AID319370, Type: Literature]
View
20
[SID49681655]
EC50 0.727Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 [AID1960, Type: confirmatory]Zinc finger protein mex- [gi:55976631]
View
21
[SID49681655]
EC50 0.727Fluorescent Polarization Homogeneous Dose Response HTS to Indentify Inhibitors of Mex-5 Binding to TCR-2 [AID1960, Type: confirmatory]Zinc finger protein mex- [gi:55976631]
View
22
[SID103226312]
IC50 0.73Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP [AID83435, Type: Literature]Reverse transcriptase/RNaseH [gi:82310930]
View
23
[SID103226312]
IC50 0.757Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate by HTRF assay [AID646974, Type: Literature]Beta-secretase 1 [gi:296434407]
View
24
[SID26719730]
Potency 0.8913qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory]Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812]
View
25
[SID103226312]
IC50 1.6Inhibition of BACE1 using Rh-EVNLDAEFK-Quencher as substrate [AID647157, Type: Literature]
View
26
[SID26719730]
Potency 1.7783qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory]euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070]
View
27
[SID103226312]
IC50 2.21Inhibition of p38alpha after 1 hr by ELISA [AID566611, Type: Literature]
View
28
[SID103226312]
IC50 3Inhibition of KDM4E [AID639775, Type: Literature]
View
29
[SID26719730]
Potency 3.1623qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory]Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581]
View
30
[SID103226312]
Ki 3.3Inhibition of MET kinase by Dixon plot analysis [AID437511, Type: Literature]
View
31
[SID103226312]
IC50 3.7Inhibition of reduced carboxymethylated kappa-casein fibril formation measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay [AID456187, Type: Literature]
View
32
[SID103226312]
IC50 6.29Inhibition of rat liver microsomal Steroid 5-alpha-reductase after 30 mins by scintillation counting [AID548975, Type: Literature]
View
33
[SID103226312]
IC50 6.44Inhibition of IDH [AID319371, Type: Literature]
View
34
[SID103226312]
IC50 6.8Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay [AID428320, Type: Literature]Matrix metalloproteinase-14 [gi:317373419]
View
35
[SID103226312]
IC50 6.8Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay [AID428320, Type: Literature]Matrix metalloproteinase-14 [gi:317373419]
View
36
[SID103226312]
IC50 6.8Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay [AID428320, Type: Literature]Matrix metalloproteinase-14 [gi:317373419]
View
37
[SID103226312]
ED50 7Antioxidant activity assessed as DPPH radical scavenging activity [AID365747, Type: Literature]
View
38
[SID103226312]
ED50 7Antioxidant activity assessed as radical DPPH scavenging activity [AID429185, Type: Literature]
View
39
[SID103226312]
ED50 8.3Antiviral activity against influenza A virus (A/swine/OH/511445/2007(H1N1)) Oh7 infected in MDCK cells assessed as inhibition of viral replication after 4 days by quantitative RT-PCR [AID638568, Type: Literature]
View
40
[SID103226312]
IC50 8.3Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry [AID650645, Type: Literature]
View
41
[SID26719730]
Potency 8.9125qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory]Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486]
View
42
[SID26719730]
Potency 8.9125qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory]bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500]
View
43
[SID103226312]
IC50 9.4Antiproliferative activity against human HL60 cells after 3 days [AID363881, Type: Literature]
View
44
[SID103226312]
IC50 9.4Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced malondialdehyde formation [AID398697, Type: other]
View
45
[SID103226312]
IC50 9.6Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay [AID428322, Type: Literature]72 kDa type IV collagenase [gi:116856]
View
46
[SID103226312]
IC50 9.6Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay [AID428322, Type: Literature]72 kDa type IV collagenase [gi:116856]
View
47
[SID103226312]
IC50 9.6Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay [AID428322, Type: Literature]72 kDa type IV collagenase [gi:116856]
View
48
[SID103226312]
IC50 9.9Antiproliferative activity against rat HSC-T6 cells after 48 hrs by MTT assay [AID312043, Type: Literature]
View
49
[SID103226312]
IC50 9.9Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 [AID265762, Type: Literature]
View
50
[SID103226312]
IC50 9.9Antifibrotic activity against rat HSC-T6 cells assessed as inhibition of proliferation after 48 hrs by BrdU incorporation assay [AID597201, Type: Literature]
View